Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $1,199 | 2 | 40.8% |
| Consulting Fee | $1,020 | 1 | 34.7% |
| Food and Beverage | $718.43 | 5 | 24.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Roche TCRC, Inc. | $1,549 | 3 | $0 (2020) |
| Novo Nordisk Inc | $1,020 | 1 | $0 (2017) |
| Genentech USA, Inc. | $149.78 | 1 | $0 (2024) |
| Alcon Laboratories Inc | $124.99 | 1 | $0 (2017) |
| Ocular Therapeutix, Inc. | $67.08 | 1 | $0 (2023) |
| F. Hoffmann-La Roche AG | $27.01 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $149.78 | 1 | Genentech USA, Inc. ($149.78) |
| 2023 | $67.08 | 1 | Ocular Therapeutix, Inc. ($67.08) |
| 2020 | $1,549 | 3 | Roche TCRC, Inc. ($1,549) |
| 2019 | $27.01 | 1 | F. Hoffmann-La Roche AG ($27.01) |
| 2017 | $1,145 | 2 | Novo Nordisk Inc ($1,020) |
All Payment Transactions
8 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/04/2024 | Genentech USA, Inc. | — | Food and Beverage | In-kind items and services | $149.78 | General |
| 11/03/2023 | Ocular Therapeutix, Inc. | DEXTENZA (Drug) | Food and Beverage | In-kind items and services | $67.08 | General |
| Category: Corticosteroid intracanalicular insert | ||||||
| 01/23/2020 | Roche TCRC, Inc. | Non-Covered Product (Drug) | Travel and Lodging | In-kind items and services | $839.38 | General |
| Category: None | ||||||
| 01/23/2020 | Roche TCRC, Inc. | Non-Covered Product (Drug) | Travel and Lodging | In-kind items and services | $359.87 | General |
| Category: None | ||||||
| 01/23/2020 | Roche TCRC, Inc. | Non-Covered Product (Drug) | Food and Beverage | In-kind items and services | $349.57 | General |
| Category: None | ||||||
| 05/01/2019 | F. Hoffmann-La Roche AG | Non-Covered Product (Drug) | Food and Beverage | In-kind items and services | $27.01 | General |
| Category: None | ||||||
| 05/11/2017 | Novo Nordisk Inc | Ozempic (Drug) | Consulting Fee | Cash or cash equivalent | $1,020.00 | General |
| Category: Diabetes | ||||||
| 05/08/2017 | Alcon Laboratories Inc | — | Food and Beverage | In-kind items and services | $124.99 | General |
About Dr. Thomas Gardner, MD
Dr. Thomas Gardner, MD is a Ophthalmology healthcare provider based in Ann Arbor, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1528022464.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thomas Gardner, MD has received a total of $2,938 in payments from pharmaceutical and medical device companies, with $149.78 received in 2024. These payments were reported across 8 transactions from 6 companies. The most common payment nature is "Travel and Lodging" ($1,199).
Practice Information
- Specialty Ophthalmology
- Other Specialties Ophthalmology
- Location Ann Arbor, MI
- Active Since 04/17/2006
- Last Updated 10/15/2010
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1528022464
Products in Payments
- Non-Covered Product (Drug) $1,576
- Ozempic (Drug) $1,020
- DEXTENZA (Drug) $67.08
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Ann Arbor
Dr. Yannis Paulus, M.d, M.D
Ophthalmology — Payments: $85,252
Dr. Amanda Bicket, M.d, M.D
Ophthalmology — Payments: $51,093
Kanishka Jayasundera
Ophthalmology — Payments: $45,504
Marguerite Weinert, Md, MD
Ophthalmology — Payments: $23,457
Mark Johnson, Md, MD
Ophthalmology — Payments: $14,023
Christine Nelson, Md, MD
Ophthalmology — Payments: $12,770